NCT06568172 2026-03-18
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
5 trialsNCT03567889 2025-12-17
NeoDREAM
Philogen S.p.A.
Phase 3 Recruiting
NCT06150144 2024-01-02
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
University of Aleppo
Phase 3 Unknown
NCT01720407 2022-12-06
ImiReduc
Nantes University Hospital
Phase 3 Completed
NCT01013623 2012-09-26
STG4SURG
Saint John's Cancer Institute
Phase 3 Terminated